A carregar...
Rasburicase (Elitek): a novel agent for tumor lysis syndrome
The overall incidence of tumor lysis syndrome in adults is not well defined, and its occurrence can be unpredictable. Several strategies are available for the prevention and treatment of tumor lysis syndrome, with rasburicase being the most recent. Rasburicase is a recombinant urate oxidase enzyme a...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baylor Health Care System
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1200736/ https://ncbi.nlm.nih.gov/pubmed/16200184 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|